Publications

The NCCN-Flatiron Outcomes Database: Collaborative Evidence Development and Quality Improvement in Oncology

Agarwala V, Birnbaum B, Gippetti J, Talcott L, Kraut J, Bowser B, Delgado J, Nightingale C, Lvov M, Nussbaum N, Connolly D, Martineau J, Darius K, Fessele K, McClure J, Fitzgerald L, Carlson R, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

Flatiron-authored

Total Cost of Care in Patients with Advanced Non-Small Cell Lung Cancer Receiving Oral Targeted Therapy vs. Standard Therapy

Gabriel PE, Berman AT, Guttman D, Stetson R, Kruse G, Morrissette J, Agarwala V, Kraut J, Abernethy AP, Shulman LN, Evans T

March 2017

Abstract

Personalized Medicine Conference-Fusion

Flatiron-authored

Chemotherapy Use Near End of Life (EOL): Measuring Real World Benchmarks

Kraut J, Gippetti J, Peterson D, Agarwala V, Revol C, Fessele K, Abernethy AP

March 2017

Abstract

ASCO Quality Care Symposium

Flatiron-authored

March 2017

Abstract

ASCO Quality Care Symposium

Flatiron-authored

March 2017

Abstract

ASCO Quality Care Symposium

Validation of Diagnosis Codes to Identify Side of Colon in an Electronic Health Record Registry

Luhn P, Kuk D, Carrigan G, Nussbaum N, Sorg R, Rohrer R, Tucker M, Arnieri B, Taylor M, Abernethy AP

January 2017

Abstract

ASCO Gastrointestinal Cancers Symposium

Flatiron-authored

January 2017

Abstract

ASCO Gastrointestinal Cancers Symposium

December 2016

Abstract

European Society for Medical Oncology ASIA

December 2016

Abstract

American Society of Hematology Annual Meeting

December 2016

Abstract

American Society of Hematology Oncology

October 2016

Abstract

EU ISPOR

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

August 2016

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

Meeting of the Canadian Urological Association

Flatiron-authored

June 2016

Abstract

ASCO Annual Meeting

Flatiron-authored

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

ASCO Annual Meeting

Flatiron-authored

March 2016

Manuscript

Clinical Lung Cancer

Flatiron-authored

March 2016

Manuscript

Future Oncology

Flatiron-authored

January 2016

Abstract

ASCO Gastrointestinal Cancers Symposium

January 2016

Abstract

ASCO Gastrointestinal Cancers Symposium

November 2015

Manuscript

Clinical Epidemiology

Flatiron-authored

September 2015

Abstract

European Cancer Congress

Flatiron-authored

Real-World Bortezomib Usage Patterns Among Patients with Relapsed/Refractory Multiple Myeloma

Calkins G, Kohansimeh J, Krishna A, Green R, Curtis MD, Lindberg F, Jaskiw A, Larrabee K, Terry M, Feinstein RN, Plotkin L, Palladino ML, Nicacio L

June 2015

Abstract

EHA Learning Center

Flatiron-authored

BRAF, KIT, and NRAS Testing Patterns and Results in Metastatic Melanoma

Abernethy AP, Fung C, Richardson P, Eisenberg D, Connolly D, Terry M, Feinstein RN, Tucker M, Miller C, Nicacio L

June 2015

Abstract

ASCO Annual Meeting

Flatiron-authored